Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic *** > Treatment > USA. G. RituxiMAb+Hyaluronidase

---

USA. G. RituxiMAb+Hyaluronidase's subsections
(*) USA Approval Date: 2017. 06.22
+Fludarabine and Cyclophosphamide
Company
Hyaluronidase Licensor:
TradeMark (Hyaluronidase)
TradeMark (RituxiMAb+Hya.) Web-Site
TradeMark (RituxiMAb+Hyaluronidase)
Web-Site

USA. G. RituxiMAb+Hyaluronidase's products
This section has no products